Haller Julia A has filed 17 insider transactions across 2 companies since December 2022.
Most recent transaction: a grant/award of 3996 shares of BRISTOL MYERS SQUIBB CO ($BMY) on February 01, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 1, 2026 | BRISTOL MYERS SQUIBB CO | $BMY | Haller Julia A | Director | A | Deferred Share Units | 3996 | $55.05 | 37,903.1540 | 2,039,000,000 | 11.79% | 0.00% |
| Oct. 3, 2025 | Outlook Therapeutics, Inc. | $OTLK | Haller Julia A | Director | A | Stock Option (Right to Buy) | 58648 | $0.00 | 58,648.0000 | 34,796,120 | 9999.99% | 0.17% |
| Oct. 1, 2025 | Outlook Therapeutics, Inc. | $OTLK | Haller Julia A | Director | A | Stock Option (Right to Buy) | 286734 | $0.00 | 286,734.0000 | 34,796,120 | 9999.99% | 0.82% |
| Feb. 1, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Haller Julia A | Director | A | Deferred Share Units | 3562 | $58.95 | 32,223.0910 | 2,027,000,000 | 12.43% | 0.00% |
| Oct. 1, 2024 | Outlook Therapeutics, Inc. | $OTLK | Haller Julia A | Not found | A | Stock Option (Right to Buy) | 56636 | $0.00 | 56,636.0000 | 18,548,813 | 9999.99% | 0.31% |
| Oct. 1, 2024 | Outlook Therapeutics, Inc. | $OTLK | Haller Julia A | Not found | A | Stock Option (Right to Buy) | 47232 | $0.00 | 47,232.0000 | 18,548,813 | 9999.99% | 0.25% |
| Oct. 3, 2024 | Outlook Therapeutics, Inc. | $OTLK | Haller Julia A | Not found | A | Stock Option (Right to Buy) | 12082 | $0.00 | 12,082.0000 | 18,548,813 | 9999.99% | 0.07% |
| March 7, 2024 | Outlook Therapeutics, Inc. | $OTLK | Haller Julia A | Not found | A | Stock Option (Right to Buy) | 94441 | $0.00 | 94,441.0000 | 13,012,833 | 9999.99% | 0.73% |
| Feb. 1, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Haller Julia A | Director | A | Deferred Share Units | 4315 | $48.67 | 27,341.2200 | 2,078,000,000 | 18.74% | 0.00% |
| Dec. 31, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Haller Julia A | Director | A | Deferred Share Units | 706 | $51.31 | 22,746.0400 | 2,146,000,000 | 3.21% | 0.00% |
| Oct. 4, 2023 | Outlook Therapeutics, Inc. | $OTLK | Haller Julia A | Director | A | Stock Option (Right to Buy) | 210225 | $0.00 | 210,225.0000 | 12,508,817 | 9999.99% | 1.68% |
| Sept. 30, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Haller Julia A | Director | A | Deferred Share Units | 625 | $58.04 | 21,797.2600 | 2,146,000,000 | 2.95% | 0.00% |
| June 30, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Haller Julia A | Director | A | Deferred Share Units | 554 | $63.95 | 20,978.3550 | 2,146,000,000 | 2.71% | 0.00% |
| March 31, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Haller Julia A | Director | A | Deferred Share Units | 487 | $69.31 | 20,255.6150 | 2,146,000,000 | 2.46% | 0.00% |
| March 29, 2023 | Outlook Therapeutics, Inc. | $OTLK | Haller Julia A | Director | A | Stock Option (Right to Buy) | 41065 | $0.00 | 41,065.0000 | 227,410,533 | 9999.99% | 0.02% |
| Feb. 1, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Haller Julia A | Director | A | Deferred Share Units | 2808 | $71.23 | 19,768.6720 | 2,146,000,000 | 16.55% | 0.00% |
| Dec. 31, 2022 | BRISTOL MYERS SQUIBB CO | $BMY | Haller Julia A | Director | A | Deferred Share Units | 469 | $71.95 | 16,826.2190 | 0 | 2.87% | 0.00% |